Claude Wischik

Research activity per year

If you made any changes in Pure these will be visible here soon.

Discovery and commercialisation of an entirely new drug for the treatment of Alzheimer's disease
Claude Wischik (Participant), Charles Harrington (Participant), John Storey (Participant), Janet Rickard (Participant), David Horsley (Participant), Thomas Baddeley (Participant), Steven Kemp (Participant), James Sinclair (Participant), Claudia Zabke (Participant), F. Theuring (Participant), F Stamer (Participant) & C Marshall (Participant)
Impact: Quality of life Impacts, Economic Impacts
Discovery and development of a new drug for the treatment of dementia
Claude Wischik (Coordinator), Charles Harrington (Coordinator), John Storey (Participant), Janet Rickard (Participant) & David Horsley (Participant)
Impact: Economic Impacts

Impacts